About this trial
The TELECONNECT-SVD study is a prospective, randomized, multicenter trial aimed at testing the efficacy of a remotely delivered exercise protocol on brain functional connectivity in patients with small vessel disease (SVD)-related ischemic stroke. The study will recruit patients aged ≥60 with a history of lacunar stroke, minimal disability (modified Rankin Scale score 0-1), and low physical activity levels.
The trial will include 60 participants randomized 1:1 to either a 24-week telecoached exercise intervention or usual care. The exercise program consists of multicomponent physical exercises delivered remotely twice a week. Assessments will be conducted at baseline, 12 weeks, 24 weeks, and 48 weeks.
Primary outcomes include changes in brain functional connectivity assessed by high-density EEG and improvements in physical fitness measured by the Senior Fitness Test. Secondary outcomes encompass changes in physical activity levels, anthropometric measurements, and vital signs.
The study employs a "wait list" design, where the control group receives the intervention after the initial 24-week period. This approach allows for assessment of the intervention's immediate effects and the retention of benefits after cessation.
Key features of the protocol include:
* Use of telecoaching to enhance adherence to the exercise program * Comprehensive assessment of brain connectivity using advanced EEG analysis techniques * Focus on patients with SVD, who may benefit significantly from exercise interventions * Evaluation of both neurophysiological and clinical outcomes
The study aims to provide evidence for the potential benefits of exercise in enhancing brain connectivity and physical fitness in SVD patients, potentially informing future treatment guidelines and preventive strategies for this population.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥60 years;
History of lacunar stroke occurred between 3 months and 10 years from screening and confirmed by neuroimaging or clinical data by an expert stroke physician;
Modified Rankin Scale (mRS) score of 0-1, indicating no symptoms or no significant disability;
A level of physical activity below recommended targets, i.e. <150 minutes per week of moderate-to-vigorous exercise (24);
Disqualifiers
Uncontrolled hypertension;
Heart disease impairing the possibility of safely following an exercise protocol at the discretion of the treating physician;
Primary or secondary epilepsy;
Prostheses, implants, and any device that might impair the performance of either high-density electroencephalogram or the exercise intervention;
Trial design
Crossover
Treatments tested in this trial
Physical activity
BehavioralRandomization to a 24-week physical exercise program
Treatment groups
Trial outcomes
Primary outcomes
Change in Senior Fitness Test score
Change in the Senior Fitness score from before to after the 24-week physical exercise intervention
Secondary outcomes
Change in International Physical Activity Questionnaire (IPAQ) score
Change in International Physical Activity Questionnaire (IPAQ) score from before to after the 24-week physical exercise intervention
Change in Body Mass Index
Change in Body Mass Index score from before to after the 24-week physical exercise intervention
Change in blood pressure
Change in blood pressure from before to after the 24-week physical exercise intervention
Change in heart rate
Change in heart rate from before to after the 24-week physical exercise intervention
Other outcomes
Change in brain functional connectivity
Overall brain functional connectivity in the resting state assessed via high-density electroencephalogram
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of L'Aquila
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborator